-
Mashup Score: 8Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Joelle Allam The University of Texas MD Anderson Cancer Center, Houston, TX Joelle Allam, Li Ma, Jeannelyn Estrella, Anneleis Willett, Karen A. Beaty, Aurelio Matamoros, Elizabeth A Lano, Keith F. Fournier, Kai Treuner, Kanwal Pratap Singh Raghav, Ryan W Huey The University of Texas MD Anderson Cancer Center, Houston, TX, Biotheranostics, A Hologic Company, San Diego, CA Background: Malignant peritoneal mesothelioma (MPeM) is a rare cancer (incidence of 0.12 per 100,000) and an arduous diagnostic challenge
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Find original research, groundbreaking studies, peer-reviewed academic literature, and publish your own manuscript on Value-Based Cancer Care.
Source: www.valuebasedcancer.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Enjoyed talking about digital health and its impact on cancer care delivery at AVBCC and taking in the other sessions from thought leaders. @VBCancerCare. https://t.co/lAYGAR3hyi https://t.co/ds580NexYk
-
-
Mashup Score: 1Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial - 8 month(s) ago
Malignant small bowel obstruction has a poor prognosis and is associated with multiple related symptoms. The optimal treatment approach is often uncle…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet-
Malignant small bowel obstruction a huge problem for our patients. Big effort here w/ @SWOG 1316 to get randomized data for surgical vs non-surgical management. No difference seen in number of "good days" (alive and out of the hospital). https://t.co/Ycm040Qnu3 https://t.co/cpmkF3uN3i
-
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 11 month(s) ago
AuthorsDeborah SchragMemorial Sloan Kettering Cancer Center, New York, NYDeborah Schrag, Qian Shi, Martin R. Weiser, Marc J Gollub, Leonard B. Saltz, Benjamin Leon Musher, Joel Goldberg, Tareq Al Baghdadi, Karyn A. Goodman, Robert R. McWilliams, Jeffrey M. Farma, Thomas J. George, Hagen Fritz Kennecke, Alan P. Venook, Eileen Mary O’Reilly, Jeffrey A. Meyerhardt, Amylou C. Dueck, Ethan Basch,…
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Perhaps an appropriate preamble to PROSPECT in the plenary session (scooped this morning by @NEJM): https://t.co/fTGtnFlHED https://t.co/6FYpvTV4Y0 #ASCO23 https://t.co/U85EsX0r7k
-
-
Mashup Score: 3
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Dr. Conroy w/ updates for PRODIGE-23 (TNT with FOLFIRINOX in LA rectal cancer). DFS 67.6 vs 62.5%, Met free survival 73.6 vs 65.4%, both favoring TNT arm. But was it the triplet or the mere presence of neoadj chemo? 🙏 JANUS trial might answer? #ASCO23 https://t.co/1SmFBHIB3f https://t.co/oaeO4hiWbc
-
-
Mashup Score: 0Feasibility and Value of Genomic-Profiling in Cancer of Unknown Primary: Real-World Evidence from Prospective Profiling Study - 11 month(s) ago
Abstract. Real-world evidence regarding the value of integrating genomic profiling (GP) in managing cancer of unknown primary (CUP) is limited. We assessed this
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet-
Happy to share our group's latest paper published in @JNCI_Now examining the use of NGS in a real world population with cancer of unknown primary. https://t.co/tb0VN3Pjm1 @kanwal_raghav @MDAndersonNews @jonathanloree
-
-
Mashup Score: 0Real-World Study Examines Genomic Profiling Challenges for Patients With Cancers of Unknown Primary - 11 month(s) ago
The researchers found that more than half of patients with CUP did not have sufficient tissue to undergo genomic profiling.
Source: Precision Medicine OnlineCategories: Hem/Oncs, Latest HeadlinesTweet-
Thanks to Precision Medicine Online for writing it up: https://t.co/jf6EyJRIrM https://t.co/qaaOBPPfV5
-
-
Mashup Score: 8Grieving in a Pandemic | NEJM - 2 year(s) ago
Perspective from The New England Journal of Medicine — Grieving in a Pandemic
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Well-stated reflection about grief: “Suffering my own loss helped me to understand how much of grief is about losing our idea of the future.” @NEJM https://t.co/blBIMQrfpt
-
-
Mashup Score: 1No Good Treatment Options, So I’ll Eat Ice Cream - The ASCO Post - 2 year(s) ago
On a warm summer afternoon, I stood in front of tables at the local farmers market loaded with my favorite fruits and vegetables: peaches, tomatoes, corn, peppers, melons, kale. I practically drooled thinking about what I could make that week: corn and tomato salad, kale and mushroom quesadillas, chilled melon soup. The…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Well-written on the nuances and struggles many face. And I’m very pro-ice cream. // No Good Treatment Options, So I’ll Eat Ice Cream - The ASCO Post https://t.co/WOsPwrr1aQ
-
-
Mashup Score: 1035Does My Son Know You? - 2 year(s) ago
Fatherhood, cancer, and what matters most
Source: The RingerCategories: Latest Headlines, Oncologists1Tweet-
RT @JonathanTjarks: Does My Son Know You? https://t.co/37lKB9pGgJ via @ringer
-
Proud of Joelle Allam, our post-doc who did great work looking at novel diagnostics in peritoneal mesothelioma. #GI24 @kanwal_raghav https://t.co/KrbmUUQzVE https://t.co/vt3gMeqQaw